Taiwan FDA registration f4a0c44edd11f08501478d59a1a527c2
A new generation of rapid pregnancy tests
TW: 新一代快速驗孕試劑
Taiwan·Risk Class 2·Lianshang Biotechnology Co., Ltd. Wugu Factory·Registered Aug 04, 2006 – Aug 04, 2011CancelledRegistration details
- Analysis ID
- f4a0c44edd11f08501478d59a1a527c2
- Customs Code
- DHY00500216501
Company information
- Manufacturer
- Lianshang Biotechnology Co., Ltd. Wugu Factory
- Manufacturer Country
- Taiwan, Province of China
- Authorized Representative
- PHARMAZON CO., LTD.
Product details
- Intended Use
- Rapid immunoassay was used to detect human placental chorionic gonadal hormone in urine.
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A.1155 Human chorionic gonadotropin testing system
- Import Information
- Contract manufacturing;; Domestic
Dates and status
- Registration Date
- Aug 04, 2006
- Expiry Date
- Aug 04, 2011
- Cancellation Date
- Nov 01, 2012
Cancellation information
- Status
- Logged out
- Reason
- 許可證已逾有效期
About this record
Access comprehensive regulatory information for A new generation of rapid pregnancy tests in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number f4a0c44edd11f08501478d59a1a527c2 and manufactured by Lianshang Biotechnology Co., Ltd. Wugu Factory. The authorized representative in Taiwan is PHARMAZON CO., LTD..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices